Capecitabine, irinotecan (CAPIRI) and sunitinib in metastatic colorectal cancer

Authors

  • M. J. Boers-Sonderen Department of Medical Oncology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  • I. M. E. Desar Department of Medical Oncology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  • M. Koopman Department of Medical Oncology, University Medical Center, Utrecht, the Netherlands
  • C. J. Punt Department of Medical Oncology, Academic Medical Center, University of Amsterdam, The Netherlands
  • C. M. L. van Herpen Department of Medical Oncology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

DOI:

https://doi.org/10.3109/0284186X.2013.806994

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2013-11-01

How to Cite

Boers-Sonderen, M. J., Desar, I. M. E., Koopman, M., Punt, C. J., & van Herpen, C. M. L. (2013). Capecitabine, irinotecan (CAPIRI) and sunitinib in metastatic colorectal cancer. Acta Oncologica, 52(8), 1778. https://doi.org/10.3109/0284186X.2013.806994

Issue

Vol. 52 No. 8 (2013): Acta Oncologica

Section

Articles